Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myeloid leukemia acute | D015470 | — | C92.0 | 4 | 6 | 2 | — | — | 10 |
Myelodysplastic syndromes | D009190 | — | D46 | 1 | 3 | 1 | — | — | 4 |
Myelomonocytic leukemia chronic | D015477 | — | C93.1 | 1 | 2 | 1 | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | 3 | — | — | — | 3 |
Colorectal neoplasms | D015179 | — | — | 3 | 2 | — | — | — | 3 |
Non-small-cell lung carcinoma | D002289 | — | — | 1 | 1 | — | — | — | 2 |
Melanoma | D008545 | — | — | 1 | 1 | — | — | — | 2 |
Fallopian tube neoplasms | D005185 | — | — | 1 | 2 | — | — | — | 2 |
Renal cell carcinoma | D002292 | EFO_0000376 | — | 1 | 2 | — | — | — | 2 |
Kidney neoplasms | D007680 | EFO_0003865 | C64 | 1 | 2 | — | — | — | 2 |
Hepatocellular carcinoma | D006528 | — | C22.0 | 1 | 1 | — | — | — | 2 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | 1 | — | — | — | 2 |
Urologic neoplasms | D014571 | — | C64-C68 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Germ cell and embryonal neoplasms | D009373 | — | — | 1 | — | — | — | — | 1 |
Testicular neoplasms | D013736 | — | C62 | 1 | — | — | — | — | 1 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | — | — | — | — | 1 |
Cholangiocarcinoma | D018281 | — | C22.1 | 1 | — | — | — | — | 1 |
Gallbladder neoplasms | D005706 | EFO_0004606 | C23 | 1 | — | — | — | — | 1 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 1 | — | — | — | — | 1 |
Castration-resistant prostatic neoplasms | D064129 | — | — | 1 | — | — | — | — | 1 |
Drug common name | Guadecitabine |
INN | guadecitabine |
Description | Guadecitabine is a small molecule pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Small molecule |
Drug class | nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | Nc1ncn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3O)[C@@H](CO)O2)c(=O)n1 |
PDB | — |
CAS-ID | 929901-49-5 |
RxCUI | — |
ChEMBL ID | CHEMBL3544916 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 2KT4YN1DP7 (ChemIDplus, GSRS) |